Chronic Myeloproliferative Neoplasm Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorIntervention: Biological: recombinant interleukin-12Sponsors: Indiana University School of Medicine; National Cancer Institute (NCI); Indiana UniversityCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorIntervention: Biological: recombinant interleukin-12Sponsors: Indiana University; Indiana University School of Medicine; National Cancer Institute (NCI)Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials
